Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy
Autor: | Inge van Rooy, Omid C. Farokhzad, Aneta J. Mieszawska, Canturk Ozcan, David P. Cormode, Artiom Petrov, Zahi A. Fayad, YongTae Kim, Matthew P. Labarre, Bram Priem, Robert Langer, Willem J. M. Mulder, Anita Gianella |
---|---|
Přispěvatelé: | ACS - Amsterdam Cardiovascular Sciences, Experimental Vascular Medicine |
Rok vydání: | 2013 |
Předmět: |
Drug
Niacinamide Fluorescence-lifetime imaging microscopy media_common.quotation_subject Microfluidics Biomedical Engineering Pharmaceutical Science Nanoparticle Mice Nude Bioengineering Nanotechnology Angiogenesis Inhibitors Article chemistry.chemical_compound Mice Drug Delivery Systems Polylactic Acid-Polyglycolic Acid Copolymer Neoplasms medicine Human Umbilical Vein Endothelial Cells Animals Humans Doxorubicin Lactic Acid media_common Pharmacology chemistry.chemical_classification Antibiotics Antineoplastic Cyclodextrin Phenylurea Compounds Organic Chemistry Optical Imaging technology industry and agriculture Polymer Sorafenib PLGA chemistry Nanoparticles Female Polyglycolic Acid Biotechnology medicine.drug Biomedical engineering |
Zdroj: | Bioconjugate chemistry, 24(9), 1429-1434. American Chemical Society |
ISSN: | 1520-4812 1043-1802 |
Popis: | For advanced treatment of diseases such as cancer, multi component, multi functional nanoparticles hold great promise. In the current study we report the synthesis of a complex nanoparticle (NP) system with dual drug loading as well as diagnostic properties. To that aim we present a methodology where chemically modified poly(lactic co glycolic) acid (PLGA) polymer is formulated into a polymer lipid NP that contains a cytotoxic drug doxorubicin (DOX) in the polymeric core and an anti angiogenic drug sorafenib (SRF) in the lipidic corona. The NP core also contains gold nanocrystals (AuNCs) for imaging purposes and cyclodextrin molecules to maximize the DOX encapsulation in the NP core. In addition, a near infrared (NIR) Cy7 dye was incorporated in the coating. To fabricate the NP we used a microfluidics based technique that offers unique NP synthesis conditions, which allowed for encapsulation and fine tuning of optimal ratios of all the NP components. NP phantoms could be visualized with computed tomography (CT) and near infrared (NIR) fluorescence imaging. We observed timed release of the encapsulated drugs, with fast release of the corona drug SRF and delayed release of a core drug DOX. In tumor bearing mice intravenously administered NPs were found to accumulate at the tumor site by fluorescence imaging. |
Databáze: | OpenAIRE |
Externí odkaz: |